Male breast cancer: a gender issue
Zeina Nahleh and Saulius Girnius
Correspondence Division of Hematology-Oncology, University of Cincinnati, The Barrett Cancer Center, ML-0501, 234 Goodman Street, Cincinnati, OH 45267, USA
Email nahlehza@ucmail.uc.edu
The incidence of male breast cancer is rising, and the treatment of this disease has been extrapolated from the knowledge of female breast cancer despite multiple differences in the pathogenesis, biology and genetics of these two disease entities. Although there have been major advances in hormonal manipulation for the treatment of breast cancer, an improved understanding of the potential differences between male and female breast cancer is essential to providing new opportunities for therapeutic intervention and likely improved outcome, as discussed in this review.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Role of aromatase inhibitors in breast cancerBritish Journal of Cancer Original Article
Sequencing of aromatase inhibitorsBritish Journal of Cancer Original Article
The effects of aromatase inhibitors on lipids and thrombosisBritish Journal of Cancer Original Article
Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screeningProstate Cancer and Prostatic Diseases Original Article
See all 5 matches for Research